Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review

Clinical Biochemistry

Volumn 41, Issue 4-5, 2008, Pages 250-259

  Worster, Andrew ^a,b   Balion, Cynthia M ^a,c   Hill, Stephen A ^a,c   Santaguida, Pasqualina ^a   Ismaila, Afisi ^a   McKelvie, Robert ^a,d   Reichert, Sonja M ^e   McQueen, Matthew J ^a,c   Booker, Lynda ^a   Raina, Parminder S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Division of Emergency Medicine   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^d Division of Cardiology   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

B type natriuretic peptide; BNP; Diagnosis; Emergency department; Meta analysis; NT proBNP; Systematic review; Urgent care

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPNEA; EMERGENCY CARE; HEART FAILURE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

DYSPNEA; EMERGENCY MEDICAL SERVICES; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY;

EID: 39149100313     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.08.008     Document Type: Article

References (42)

1. Doust J.A., Glasziou P.P., Pietrzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch. Intern. Med. 164 (2004) 1978-1984
2. Bales A.C., and Sorrentino M.J. Causes of congestive heart failure. Prompt diagnosis may affect prognosis. Postgrad. Med. 101 (1997) 44-46
3. Wuerz R.C., and Meador S.A. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann. Emerg. Med. 21 (1992) 669-674
4. Wang C.S., FitzGerald J.M., Schulzer M., Mak E., and Ayas N.T. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA 294 (2005) 1944-1956
5. Balion C., Santaguida P., Hill S., et al. A systematic review of the evidence on the testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure (2006), Agency for Healthcare Research and Quality, Rockville, MD
6. Karl J., Borgya A., Gallusser A., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand. J. Clin Lab. Invest. Suppl. 230 (1999) 177-181
7. Hunt P.J., Richards A.M., Nicholls M.G., et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. (Oxf.) 47 (1997) 287-296
8. Troughton R.W., Frampton C.M., Yandle T.G., et al. Plasma amino-terminal B-type natriuretic peptide measured by Elecsys 2010 assay in a trial of hormone-guided treatment for heart failure. Clin. Chem. 49 (2003) 1212-1215
9. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin. Chem. 49 (2003) 976-979
10. Whiting P., Rutjes A., Reitsma J., Bossuyt P., and Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med. Res. Methodol. 3 (2003) 25
11. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., and Bossuyt P.M. The diagnostic odds ratio: a single indicator of test performance. J. Clin. Epidemiol. 56 (2003) 1129-1135
12. Deville W.L., Buntinx F., Bouter L.M., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med. Res. Methodol. 2 (2002) 9
13. Zamora J., Abraira V., Muriel A., Khan K., and Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med. Res. Methodol. 6 (2006) 31
14. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
15. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
16. Deeks J.J., and Deeks J.J. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323 (2001) 157-162
17. Walter S.D. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat. Med. 21 (2002) 1237-1256
18. Maisel A.S., Clopton P., Krishnaswamy P., et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am. Heart J. 147 (2004) 1078-1084
19. Knudsen C.W., Omland T., Clopton P., et al. Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am. J. Med. 116 (2004) 363-368
20. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
21. Maisel A.S., Krishnaswamy P., and Nowak R.M. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. [summary for patients in J Fam Pract. 2002 Oct;51(10):816; PMID: 12401145]. N. Engl. J. Med. 347 (2002) 161-167
22. Knudsen C.W., Riis J.S., Finsen A.V., et al. Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender. Eur. J. Heart Fail. 6 (2004) 55-62
23. Morrison L.K., Harrison A., Krishnaswamy P., et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J. Am. Coll. Cardiol. 39 (2002) 202-209
24. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J. Am. Coll. Cardiol. 37 (2001) 379-385
25. Barcarse E., Kazanegra R., Chen A., et al. Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest. Heart Fail. 10 (2004) 171-176
26. Villacorta H., Duarte A., Duarte N.M., et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq. Bras. Cardiol. 79 (2002) 569-572
27. Logeart D., Saudubray C., Beyne P., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J. Am. Coll. Cardiol. 40 (2002) 1794-1800
28. Ray P., Arthaud M., Lefort Y., et al. Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med. 30 (2004) 2230-2236
29. Bayes-Genis A., Santalo-Bel M., and Zapico-Muniz E. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur. J. Heart Fail. 6 (2004) 301-308
30. Jose J.V., Gupta S.N., and Selvakumar D. Utility of N-terminal pro-brain natriuretic peptide for the diagnosis of heart failure. Indian Heart J. 55 (2003) 35-39
31. Lainchbury J.G., Campbell E., Frampton C.M., et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J. Am. Coll. Cardiol. 42 (2003) 728-735
32. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study 2005. Eur. Heart J. 27 3 (2006) 330-337
33. Battaglia M., Pewsner D., Juni P., et al. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch. Intern. Med. 166 (2006) 1073-1080
34. Okada K., Minamino T., Tsukamoto Y., et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110 (2004) 705-712
35. Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-type natriuretic peptide assays. Clin. Chem. 51 3 (2005) 486-493
36. Hammerer-Lercher A., Ludwig W., Falkensammer G., et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin. Chem. 50 (2004) 1174-1183
37. Fischer Y., Filzmaier K., Stiegler H., et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin. Chem. 47 (2001) 591-594
38. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 9088 (1997) 1349-1353
39. Morgan S., Smith H., Simpson I., et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ 318 (1999) 368-372
40. McDonagh T.A., Morrison C.E., Lawrence A., et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350 (1997) 829-833
41. Raymond I., Groenning B.A., Hildebrandt P.R., et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
42. Moher D., Pham B., Lawson M.L., and Klassen T.P. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol. Assess. 7 (2003) 1-90